SORT1 rs12747330: LDL Cholesterol and Heart Health
The genetic variant rs12747330 is a noncoding single-nucleotide polymorphism located in the 1p13 chromosomal region near the SORT1 gene. It is part of a well-studied regulatory haplotype associated with altered hepatic SORT1 expression, circulating low-density lipoprotein cholesterol (LDL-C) levels, and risk of coronary artery disease. Understanding your genotype provides insight into one of many inherited factors influencing lifetime lipid metabolism.
What each genotype means
Baseline LDL-C association
This genotype is associated with higher hepatic SORT1 expression levels compared to the G allele. Research indicates this expression pattern is linked to lower plasma LDL-C levels and a potentially lower risk of coronary artery disease.
This is the major genotype in most populations, carried by approximately 55-65% of individuals of European ancestry.
Intermediate LDL-C association
Carrying one copy of the G allele results in an intermediate effect on SORT1 expression levels in the liver. This genotype is associated with moderate plasma LDL-C levels compared to those who carry two copies of the C or G alleles.
This heterozygous genotype is found in approximately 30-35% of individuals of European ancestry.
Increased LDL-C risk association
This genotype is associated with lower hepatic SORT1 expression, which research links to higher plasma LDL-C levels. Individuals with this genotype may have a statistically higher risk of coronary artery disease, though this effect is complex and influenced by many other genetic and lifestyle factors.
The G allele is the minor allele, and this homozygous genotype is found in approximately 4-6% of individuals of European ancestry.
Genomic Location and the 1p13 Regulatory Locus
The single-nucleotide polymorphism rs12747330 resides on chromosome 1 at band 1p13.3, a genomic neighborhood that has drawn substantial attention in cardiovascular genetics. This variant is situated within an intergenic regulatory region in close proximity to three genes: SORT1 (sortilin 1), CELSR2, and PSRC1. Rather than directly altering a protein-coding sequence, rs12747330 resides in a dense block of linkage disequilibrium alongside other noncoding regulatory variants, most notably rs12740374. Functional genomics investigations demonstrate that this regulatory cluster modifies local chromatin architecture and alters the binding affinity of liver transcription factors, acting as an expression quantitative trait locus (eQTL) that modulates how vigorously neighboring genes are transcribed in hepatic tissue.
The Biological Function of the SORT1 Gene
The SORT1 gene encodes sortilin 1, a multi-ligand transmembrane sorting receptor that predominantly traffics proteins between the trans-Golgi network, endosomes, lysosomes, and the cell surface. In hepatocytes, sortilin plays a central role in cholesterol homeostasis by physically interacting with apolipoprotein B-100 (apoB-100), the structural backbone of very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) particles. While early experimental models showed complex dynamics regarding sortilin expression, functional studies in human liver cells and targeted models indicate that sortilin influences both the secretion of newly assembled apoB-containing lipoproteins and the lysosomal uptake and degradation of circulating LDL particles. Through these dual mechanisms, variation in sortilin abundance directly shifts systemic cholesterol clearance.
Cardiovascular Associations and Research Evidence
Large-scale genome-wide association studies (GWAS) and Mendelian randomization investigations have repeatedly linked the 1p13 locus with circulating LDL cholesterol levels and myocardial infarction risk. The minor G allele of rs12747330 tracks with enhanced hepatic SORT1 transcription, which correlates with modestly lower average circulating LDL-C levels and a reduced risk of coronary artery disease across large cohorts. However, the catalog evidence strength for this specific tag variant remains categorized as limited to moderate because rs12747330 acts primarily as part of an extended haplotype block. Isolating its independent, standalone causal effect from neighboring regulatory variants like rs12740374 remains challenging, and published mechanistic models continue to debate the precise directionality of sortilin manipulation across different model systems.
Population Frequency and Ancestral Distribution
Allele frequencies for rs12747330 vary considerably across global ancestries due to historical human migration and genetic drift. In individuals of European and East Asian descent, the minor G allele occurs at an estimated frequency of approximately 0.20 to 0.25, making the homozygous TT genotype the most prevalent background in these groups. In contrast, frequencies differ in African and admixed populations, where shorter linkage disequilibrium blocks often break the correlation between rs12747330 and other 1p13 regulatory markers. This divergence underscores the importance of interpreting genetic findings within the context of specific ancestral backgrounds, as a tag SNP's statistical predictive power depends heavily on the surrounding genomic architecture.
Clinical Realities: What This Information Means for You
While learning your rs12747330 genotype provides educational insight into your baseline biological tendencies, it cannot diagnose cardiovascular disease or guarantee heart health. Polygenic traits such as blood cholesterol and atherosclerosis risk are shaped by hundreds of genetic variants acting in concert with diet, physical activity, smoking status, and age. Having a favorable genotype does not make an individual immune to hypercholesterolemia, nor does carrying higher-risk alleles mean coronary heart disease is inevitable. Standard clinical blood panels, such as a fasting lipid profile, remain the definitive tool for evaluating cardiovascular health. Any potential lifestyle modifications or questions regarding lipid-lowering therapies should always be discussed directly with a qualified healthcare provider.
How common is this variant?
The minor G allele has a frequency of roughly 0.20 to 0.25 in European and East Asian ancestral populations, with the majority of individuals carrying the TT genotype. Frequencies and linkage disequilibrium patterns can vary noticeably in other ancestral groups, such as populations of African descent.
Frequently asked questions
Does having the rs12747330 G allele mean I will never have high cholesterol?
No. While the G allele is statistically associated with lower average LDL cholesterol, it contributes only a small fraction of your total cardiovascular risk profile. Nutrition, exercise, metabolic factors, and hundreds of other genes play substantial roles in determining your actual blood lipid concentrations.
Can rs12747330 be used to diagnose coronary artery disease?
No, this single-nucleotide polymorphism is not a diagnostic test. It is a common susceptibility variant that confers subtle statistical shifts in cholesterol metabolism across populations rather than directly causing or ruling out heart disease.
How does the SORT1 gene influence LDL cholesterol in the body?
SORT1 encodes the protein sortilin, which aids in sorting and trafficking apolipoprotein B-containing particles in liver cells. Altered sortilin levels modify both how lipoproteins are secreted from the liver and how efficiently circulating LDL particles are cleared from the bloodstream.
Should I change my diet or medications based on my rs12747330 genotype?
You should not make changes to your medical care or prescription medications based solely on this genetic variant. Clinical blood tests and direct guidance from your physician or lipid specialist are the established standards for managing cholesterol and cardiovascular wellness.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12747330?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in SORT1
Functional regulatory variant altering SORT1 hepatic expression, predisposing to altered LDL cholesterol levels and myocardial infarction risk.
Variant in SORT1 significantly associated with LDL cholesterol levels and coronary artery disease risk.
A regulatory variant at the 1p13 locus near SORT1/CELSR2 that strongly influences LDL-C levels and coronary artery disease risk.
This variant influences LDL cholesterol levels and is a significant marker for cardiovascular health.
This SNP is linked to variations in LDL cholesterol levels and risk of coronary artery disease.